SG10201701063WA - Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same - Google Patents
Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing sameInfo
- Publication number
- SG10201701063WA SG10201701063WA SG10201701063WA SG10201701063WA SG10201701063WA SG 10201701063W A SG10201701063W A SG 10201701063WA SG 10201701063W A SG10201701063W A SG 10201701063WA SG 10201701063W A SG10201701063W A SG 10201701063WA SG 10201701063W A SG10201701063W A SG 10201701063WA
- Authority
- SG
- Singapore
- Prior art keywords
- aqueous dispersion
- encapsulating liposome
- liposome aqueous
- stable oxaliplatin
- stabilizing same
- Prior art date
Links
- 239000006185 dispersion Substances 0.000 title 1
- 239000002502 liposome Substances 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012178971 | 2012-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201701063WA true SG10201701063WA (en) | 2017-04-27 |
Family
ID=50068258
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201701063WA SG10201701063WA (en) | 2012-08-10 | 2013-08-09 | Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same |
| SG11201501010QA SG11201501010QA (en) | 2012-08-10 | 2013-08-09 | Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201501010QA SG11201501010QA (en) | 2012-08-10 | 2013-08-09 | Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10383822B2 (en) |
| EP (1) | EP2883542B1 (en) |
| JP (1) | JP6230538B2 (en) |
| CN (1) | CN104703594B (en) |
| ES (1) | ES2733061T3 (en) |
| SG (2) | SG10201701063WA (en) |
| WO (1) | WO2014025042A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015012200A (en) * | 2013-03-13 | 2015-11-30 | Mallinckrodt Llc | Liposome oxaliplatin compositions for cancer therapy. |
| EP3350222B1 (en) | 2015-09-18 | 2021-10-20 | Technische Universität München | Ligands for integrin avbeta6, synthesis and uses thereof |
| BR112019003946A2 (en) | 2016-08-31 | 2019-05-21 | Fujifilm Corporation | antitumor agent, antitumor effect booster and antitumor kit |
| WO2018167295A1 (en) | 2017-03-17 | 2018-09-20 | Technische Universität München | LIGANDS FOR INTEGRIN αvβ8, SYNTHESIS AND USES THEREOF |
| MX2018002611A (en) | 2018-01-29 | 2019-07-30 | Fujifilm Corp | Antitumor agent for biliary cancer and treatment method of biliary cancer. |
| CN111836628B (en) * | 2018-03-13 | 2025-01-07 | 富士胶片株式会社 | Antitumor agent, antitumor effect enhancer, and antitumor kit |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1270198A (en) | 1984-08-08 | 1990-06-12 | Marcel B. Bally | Encapsulation of antineoplastic agents in liposomes |
| JP3218637B2 (en) | 1990-07-26 | 2001-10-15 | 大正製薬株式会社 | Stable aqueous liposome suspension |
| EP0750910A4 (en) * | 1994-03-11 | 1997-07-09 | Yoshitomi Pharmaceutical | LIPOSOME PREPARATION |
| ATE197249T1 (en) | 1994-08-08 | 2000-11-15 | Debiopharm Sa | STABLE MEDICINAL PRODUCT CONTAINING OXALIPLATIN |
| GB9420390D0 (en) * | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
| DE19648650C2 (en) | 1996-01-29 | 1998-07-02 | Schering Ag | Buffer systems and their use to stabilize pharmaceutical preparations |
| CA2247270A1 (en) | 1996-02-26 | 1997-08-28 | Daiichi Pharmaceutical Co., Ltd. | Liposome and liposome dispersion |
| DK0850646T3 (en) | 1996-06-18 | 2008-05-13 | Kyowa Hakko Kogyo Kk | Liposome preparations of indolocarbazole derivatives |
| JP4368513B2 (en) | 1999-12-27 | 2009-11-18 | 富士フイルム株式会社 | Image processing method and apparatus, and recording medium |
| JP3415131B1 (en) * | 2002-06-03 | 2003-06-09 | メビオファーム株式会社 | Liposome preparation |
| US20040022842A1 (en) * | 2002-06-03 | 2004-02-05 | Mebiopharm Co., Ltd. | Liposome preparations containing oxaliplatin |
| US20040002284A1 (en) * | 2002-06-27 | 2004-01-01 | Leal Jose E. | Illuminated throwing toy |
| CN100471493C (en) * | 2003-12-17 | 2009-03-25 | 梅比欧法姆股份有限公司 | Liposome preparation containing Oxaliplatin |
| LT3173073T (en) * | 2004-05-03 | 2025-01-10 | Ipsen Biopharm Ltd. | Liposomes for drug delivery |
| JP2006248978A (en) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | New liposome preparation |
| US8078919B2 (en) * | 2005-06-14 | 2011-12-13 | Hitachi Global Storage Technologies Netherlands B.V. | Method, apparatus and program storage device for managing multiple step processes triggered by a signal |
| GR20060100144A (en) * | 2006-03-03 | 2007-10-17 | Cancer treatment using oxaliplatin encapsulated into liposomes and co-encapsulation into the liposome particle of more than one pharmaceutical preparations, or genes | |
| WO2008030818A2 (en) * | 2006-09-05 | 2008-03-13 | Mebiopharm Co., Ltd. | Novel liposome compositions |
| TWI468188B (en) | 2008-01-30 | 2015-01-11 | Univ Tokushima | Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation |
| EP2123258A1 (en) * | 2008-05-23 | 2009-11-25 | Liplasome Pharma A/S | Liposomes for drug delivery |
-
2013
- 2013-08-09 US US14/420,544 patent/US10383822B2/en active Active
- 2013-08-09 ES ES13827386T patent/ES2733061T3/en active Active
- 2013-08-09 WO PCT/JP2013/071720 patent/WO2014025042A1/en active Application Filing
- 2013-08-09 EP EP13827386.7A patent/EP2883542B1/en active Active
- 2013-08-09 CN CN201380052752.6A patent/CN104703594B/en active Active
- 2013-08-09 SG SG10201701063WA patent/SG10201701063WA/en unknown
- 2013-08-09 SG SG11201501010QA patent/SG11201501010QA/en unknown
- 2013-08-09 JP JP2014529582A patent/JP6230538B2/en active Active
-
2019
- 2019-07-03 US US16/502,798 patent/US10993913B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6230538B2 (en) | 2017-11-15 |
| US20190321294A1 (en) | 2019-10-24 |
| CN104703594B (en) | 2018-01-23 |
| JPWO2014025042A1 (en) | 2016-07-25 |
| EP2883542A1 (en) | 2015-06-17 |
| US20150216801A1 (en) | 2015-08-06 |
| US10383822B2 (en) | 2019-08-20 |
| US10993913B2 (en) | 2021-05-04 |
| HK1210035A1 (en) | 2016-04-15 |
| SG11201501010QA (en) | 2015-04-29 |
| WO2014025042A1 (en) | 2014-02-13 |
| ES2733061T3 (en) | 2019-11-27 |
| CN104703594A (en) | 2015-06-10 |
| EP2883542B1 (en) | 2019-05-01 |
| EP2883542A4 (en) | 2016-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL238250A0 (en) | Selective antisense compounds and uses thereof | |
| GB2500915B (en) | Arrangement and method | |
| ZA201409071B (en) | Controlled environment and method | |
| EP2898720A4 (en) | Systems and methods for interference alignment in wi-fi | |
| IL236036A0 (en) | Pyridinone and pyridazione derivatives | |
| EP2866390A4 (en) | Communication method and system | |
| SG11201406006XA (en) | Controlled sympathectomy and micro-ablation systems and methods | |
| IL237746B (en) | Electrode assembly and method for its preparation | |
| EP2907501A4 (en) | Cosmetic method | |
| PT2822936T (en) | Aminoquinoline derivatives and uses thereof | |
| EP2907500A4 (en) | Cosmetic method | |
| EP2828615A4 (en) | Lasergrammetry system and methods | |
| GB201208548D0 (en) | Compound and method | |
| GB201219800D0 (en) | System and method | |
| GB2509397B (en) | Rigid-stem active method and system | |
| EP2774602A4 (en) | Aqueous dispersion and method for producing same | |
| GB201223260D0 (en) | Methods and apparatuses for facilitating communications | |
| ZA201504003B (en) | Stabilizing system | |
| EP3041901A4 (en) | Aqueous polyurethane dispersion | |
| SG11201501010QA (en) | Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same | |
| PT2812291T (en) | Aqueous dispersion | |
| EP2894197A4 (en) | Aqueous dispersion, and additive for fracturing work | |
| PL2940007T3 (en) | Tyrosine derivative and manufacturing method for tyrosine derivative | |
| IL224860A0 (en) | Methods for preparing targeted liposome complexes and uses thereof | |
| EP2805956A4 (en) | Gambogenic acid derivatives, preparation method and application thereof |